Epigenetic Modification Restores Functional PR Expression in Endometrial Cancer Cells

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|11|1874-1880

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.11, 2014-04, pp. : 1874-1880

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of Monocyte Chemotactic Protein-1 in Human Endometrial Cancer Cells and the Effect of Treatment with Tamoxifen or Buserelin

By Wang L   Zheng W   Zhang S   Chen X   Hornung D  

The Journal of International Medical Research, Vol. 34, Iss. 3, 2006-05 ,pp. : 284-290

Field House Publishing

Access to resources Recommend Favorite

Epigenetic Interventions Increase the Radiation Sensitivity of Cancer Cells

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1857-1865

Bentham Science Publishers

Access to resources Recommend Favorite

Lung Cancer Stem Cells: An Epigenetic Perspective

By  

Current Cancer Drug Targets, Vol. 18, Iss. 1, 2017-12 ,pp. : 16-31

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Modification in Neuropathic Pain

By  

Current Pharmaceutical Design, Vol. 21, Iss. 7, 2015-02 ,pp. : 849-867

Bentham Science Publishers

Access to resources Recommend Favorite

Cytostatic and Apoptotic Effects of DNMT and HDAC Inhibitors in Endometrial Cancer Cells

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1881-1887

Bentham Science Publishers

Access to resources Recommend Favorite